Replies to post #190519 on Biotech Values

[DewDiligence]

MYL is not worth “significantly more than $100 per share” or even $100/sh flat, IMO. I think the portion of the PR highlighted in red is just for show; other rhetoric in the PR is gratuitous and shows Robert Coury to be a loose cannon.